CD38
Plasma cell antigen targeted by daratumumab and isatuximab in multiple myeloma.
No Clinical Trials found for this biomarker.
Plasma cell antigen targeted by daratumumab and isatuximab in multiple myeloma.
No Clinical Trials found for this biomarker.